Nutritional aspects and health benefits of bioactive plant compounds against infectious diseases: a review

MT El-Saadony, NM Zabermawi… - Food Reviews …, 2023 - Taylor & Francis
In the current century, the development of medicine and molecular biotechnology led to
successful containment and even eradication of some human pathogens, especially in …

Influenza vaccines: challenges and solutions

K Houser, K Subbarao - Cell host & microbe, 2015 - cell.com
Vaccination is the best method for the prevention and control of influenza. Vaccination can
reduce illness and lessen severity of infection. This review focuses on how currently …

Immunosenescence: influenza vaccination and the elderly

K Haq, JE McElhaney - Current opinion in immunology, 2014 - Elsevier
Highlights•Aging is associated with a decline in immune function termed 'immune
senescence'.•Effective influenza vaccines need to be developed for better protection the …

Platforms, advances, and technical challenges in virus-like particles-based vaccines

R Gupta, K Arora, SS Roy, A Joseph… - Frontiers in …, 2023 - frontiersin.org
Viral infectious diseases threaten human health and global stability. Several vaccine
platforms, such as DNA, mRNA, recombinant viral vectors, and virus-like particle-based …

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch

S Hirobe, H Azukizawa, T Hanafusa, K Matsuo… - Biomaterials, 2015 - Elsevier
Transcutaneous immunization (TCI) is an attractive vaccination method compared with
conventional injectable vaccines because it is easier to administer without pain. We …

The weight of obesity on the human immune response to vaccination

SD Painter, IG Ovsyannikova, GA Poland - Vaccine, 2015 - Elsevier
Despite the high success of protection against several infectious diseases through effective
vaccines, some sub-populations have been observed to respond poorly to vaccines, putting …

Virus‐like particles as powerful vaccination strategy against human viruses

I Hadj Hassine, M Ben M'hadheb… - Reviews in Medical …, 2024 - Wiley Online Library
Nowadays, viruses are not only seen as causative agents of viral infectious diseases but
also as valuable research materials for various biomedical purposes, including recombinant …

[HTML][HTML] Baloxavir marboxil single-dose treatment in influenza-infected children: a randomized, double-blind, active controlled phase 3 safety and efficacy trial …

J Baker, SL Block, B Matharu… - The Pediatric …, 2020 - journals.lww.com
Background: Baloxavir marboxil (baloxavir) is a novel, cap-dependent endonuclease
inhibitor that has previously demonstrated efficacy in the treatment of influenza in adults and …

Influenza vaccine: Where are we and where do we go?

M Keshavarz, H Mirzaei, M Salemi… - Reviews in medical …, 2019 - Wiley Online Library
The alarming rise of morbidity and mortality caused by influenza pandemics and epidemics
has drawn attention worldwide since the last few decades. This life‐threatening problem …

[PDF][PDF] Virus like particles as immunogens and universal nanocarriers

A Naskalska, K Pyrć - 2015 - ruj.uj.edu.pl
Over the last two decades virus‑like particles (VLPs) have become an important tool in
biomedical research and medicine. VLPs are multi‑protein structures that resemble viable …